Can Better Biomarkers Reduce Drug Failure? - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Can Better Biomarkers Reduce Drug Failure?

How next-generation biomarker strategies could improve patient stratification, strengthen clinical trials, and reduce the cost of drug development

  • By

  • Andreas Wolf

  • November 12, 2026

  • 7 min

Share

Original Source(s)

Can Better Biomarkers Reduce Drug Failure?

  • by Andreas Wolf

  • November 12, 2026

Related Content

ACP, OpenEvidence partner on clinical AI

The collaboration aims to put trusted clinical evidence within reach during patient encounters.

IFITM1 and CTSS may help identify Sjögren’s dry eye

Investigators identified 2 histamine-related genes associated with keratoconjunctivitis sicca and found that suppressing either gene reduced inflammatory injury in corneal epithelial cells.

Five Types of Fatty Liver Disease Revealed

Study identifies distinct genetic and clinical profiles that could improve risk assessment and personalize care for patients with fatty liver disease

  • November 10, 2026

  • 2 min